The global colorectal cancer molecular diagnostics market has been forecasted to soar, reaching a staggering value of US$ 5.07 Billion by 2032, according to recent market analysis. Garnering a market value of US$ 2.35 Billion in 2022, this projected growth represents a robust Compound Annual Growth Rate (CAGR) of 8% during the assessment period of …